Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN14484575Phase 4Completed
Phase 4, randomised, open-label trial in iron deficiency anemia (IDA) comparing Ferric carboxymaltose with Iron sucrose (2 arms). Primary endpoints: Effectiveness and safety based on laboratory biomarkers at week 4, Drug-related problems at week 4 and 1 more. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN14484575.